quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
in patients with covid	153
at the time of	88
of venous thromboembolism in	74
hospitalized patients with covid	70
in patients with severe	65
in the setting of	57
acute respiratory distress syndrome	53
a retrospective chart review	51
in critically ill patients	46
a total of patients	45
retrospective chart review of	45
in hospitalized patients with	44
in the absence of	43
severe acute respiratory syndrome	42
critically ill patients with	41
with sickle cell disease	41
patients admitted to the	39
article is protected by	37
is protected by copyright	37
this article is protected	37
acutely ill medical patients	35
icu patients with covid	35
were more likely to	35
thromboembolism in patients with	35
of vte in patients	34
vte in patients with	34
venous thromboembolism in patients	34
for the treatment of	34
in acutely ill medical	33
we performed a retrospective	30
of this study was	30
acute respiratory syndrome coronavirus	30
the purpose of this	30
in patients with acute	29
of patients with covid	28
in the united states	28
incidence of thrombotic complications	28
venous thromboembolism in hospitalized	28
of thrombotic complications in	28
in the treatment of	27
this study was to	27
the intensive care unit	27
ill patients with covid	27
thrombotic complications in critically	26
in the presence of	26
complications in critically ill	26
should be considered in	25
of this study is	25
patients with sickle cell	25
were included in the	25
in critically ill icu	25
critically ill icu patients	25
this is the first	25
patients with coronavirus disease	25
at the end of	25
is associated with decreased	24
patients at risk for	24
thromboembolism in hospitalized patients	24
for the prevention of	24
this study is to	24
severe novel coronavirus pneumonia	24
ill icu patients with	24
in pediatric patients with	24
with a history of	24
as well as the	24
was found to have	23
a retrospective review of	23
patients with severe novel	23
incidence of vte in	23
in the management of	23
prevalence of venous thromboembolism	23
patients with novel coronavirus	23
during the study period	23
with severe novel coronavirus	23
we report a case	22
we conducted a retrospective	22
the risk of vte	22
in this patient population	22
and management of coagulopathy	22
american society of hematology	22
associated with poor prognosis	22
are associated with poor	21
has been associated with	21
report a case of	21
the incidence of vte	21
society on thrombosis and	21
prevention of venous thromboembolism	21
treatment of venous thromboembolism	21
has been shown to	21
prognosis in patients with	20
more likely to have	20
and treatment of vte	20
purpose of this study	20
in the context of	20
treatment is associated with	20
of the patients with	19
there was no difference	19
is the most common	19
poor prognosis in patients	19
with decreased mortality in	19
low molecular weight heparin	19
associated with decreased mortality	19
prevention and treatment of	19
severe coronavirus disease patients	19
studies are needed to	19
was associated with a	19
with poor prognosis in	19
pulmonary embolism in covid	19
in severe coronavirus disease	19
diagnosis and management of	19
a retrospective cohort study	19
coagulation parameters are associated	19
mortality in severe coronavirus	19
parameters are associated with	19
anticoagulant treatment is associated	19
disease patients with coagulopathy	19
efficacy and safety of	19
coronavirus disease patients with	19
decreased mortality in severe	19
it is important to	19
for the management of	18
management of patients with	18
in children with scd	18
the presence of a	18
an increased risk of	18
of deep vein thrombosis	18
medical patients at risk	18
with novel coronavirus pneumonia	18
to the intensive care	18
patients with severe covid	18
the mean age was	18
and treatment of venous	18
was no difference in	18
risk of vte in	18
abnormal coagulation parameters are	18
in patients with novel	18
n a l p	17
activated partial thromboplastin time	17
the padua prediction score	17
j o u r	17
the american college of	17
we present a case	17
there was no significant	17
systematic review and meta	17
retrospective chart review was	17
hospitalized medical patients at	17
l p r e	17
o u r n	17
guidelines for management of	17
u r n a	17
risk for venous thromboembolism	17
r n a l	17
was found to be	17
a l p r	17
is associated with a	17
r o o f	17
p r o o	17
of coagulopathy in covid	17
and risk factors for	17
is one of the	16
on thrombosis and haemostasis	16
in a patient with	16
risk factors for vte	16
hematopoietic stem cell transplant	16
in patients with scd	16
incidence of venous thromboembolism	16
of patients admitted to	16
deep vein thrombosis in	16
international society on thrombosis	16
treatment of vte in	16
in patients with a	16
management of venous thromboembolism	16
thrombosis in patients with	16
to be associated with	16
management of coagulopathy in	16
of patients infected with	16
of vte in covid	15
review of the literature	15
the case of a	15
little is known about	15
be considered in patients	15
total of patients were	15
in the pediatric population	15
admitted to the icu	15
the diagnosis and management	15
has been reported in	15
patients admitted to an	15
for management of venous	15
the primary efficacy outcome	15
the international society on	15
on recognition and management	15
over the course of	15
admitted to the intensive	15
was not associated with	15
recognition and management of	15
in critically ill covid	15
thromboembolic complications in covid	15
of morbidity and mortality	15
in medically ill patients	14
as a result of	14
guidance on recognition and	14
those who did not	14
at increased risk of	14
the aim of this	14
interim guidance on recognition	14
the majority of patients	14
in the neurocritical care	14
for the diagnosis and	14
with a diagnosis of	14
a case of a	14
and is associated with	14
found to have a	14
hematopoietic stem cell transplantation	14
the world health organization	14
isth interim guidance on	14
objective of this study	14
patients hospitalized for covid	13
the objective of this	13
a median age of	13
at the university of	13
a higher risk of	13
a higher incidence of	13
of adult inpatients with	13
venous and arterial thromboembolic	13
factors for mortality of	13
at risk for venous	13
describe a case of	13
in a cohort of	13
for mortality of adult	13
course and risk factors	13
children with sickle cell	13
reported in the literature	13
venous thromboembolic events in	13
risk of thrombosis in	13
guideline and expert panel	13
a systematic review and	13
chest guideline and expert	13
there were no significant	13
a year old male	13
with acute brain injury	13
thrombotic or thromboembolic disease	13
risk factors for mortality	13
adult inpatients with covid	13
mortality of adult inpatients	13
and expert panel report	13
the prevention of venous	13
the end of the	13
at increased risk for	13
chart review of patients	13
upper limit of normal	13
clinical course and risk	13
and thrombotic or thromboembolic	13
may be associated with	13
of thrombosis in patients	13
admitted to intensive care	13
therapy and prevention of	12
the management of patients	12
high risk of vte	12
year old male with	12
arterial thromboembolic complications in	12
venous thromboembolism prophylaxis in	12
mortality in patients with	12
the neurocritical care unit	12
in patients hospitalized with	12
patients with atrial fibrillation	12
included in the study	12
aim of this study	12
a risk assessment model	12
of critically ill patients	12
the time of the	12
admitted to an academic	12
in the development of	12
a mean age of	12
associated with a higher	12
no significant differences in	12
performed a retrospective chart	12
of sickle cell disease	12
in patients admitted to	12
was significantly higher in	12
were found to have	12
the upper limit of	12
antithrombotic therapy and prevention	12
review of patients with	12
was the most common	12
the severe acute respiratory	12
and prevention of thrombosis	12
multicenter prospective cohort study	12
one of the most	12
a multicenter prospective cohort	12
patients with and without	12
high risk of thrombosis	12
with acute ischemic stroke	12
american college of cardiology	12
who did not receive	12
compared to those without	12
risk assessment model for	12
a year old female	12
of hospitalized medical patients	11
with severe hemophilia a	11
for the identification of	11
and arterial thromboembolic complications	11
of hospitalized patients with	11
with the use of	11
increased risk of vte	11
patients admitted to a	11
patients with acute brain	11
with increased risk of	11
society of hematology guidelines	11
she was started on	11
to the emergency department	11
middle east respiratory syndrome	11
at the start of	11
a retrospective analysis of	11
is known about the	11
of an increased prevalence	11
cause of morbidity and	11
all patients admitted to	11
more likely to be	11
the efficacy and safety	11
and disseminated intravascular coagulation	11
the results of this	11
identification of hospitalized medical	11
the first case of	11
hematology guidelines for management	11
awareness of an increased	11
patients admitted to intensive	11
model for the identification	11
at a median of	11
all hospitalized patients with	11
of hematology guidelines for	11
area under the curve	11
the identification of hospitalized	11
with a median age	11
are at increased risk	11
patients admitted to our	11
admitted to the hospital	11
chart review of all	11
should be considered for	11
risk of venous thromboembolism	11
in hospitalized medical patients	11
high index of suspicion	10
in the emergency department	10
clinical characteristics of coronavirus	10
the mrna expressions of	10
prevalence of vte in	10
for the duration of	10
a median of days	10
none of the patients	10
of the patients who	10
research is needed to	10
increased risk for vte	10
associated with increased risk	10
the quality of life	10
white blood cell count	10
coagulopathy and disseminated intravascular	10
to describe a case	10
of acute pulmonary embolism	10
outcomes in patients with	10
characteristics of coronavirus disease	10
present a case of	10
thromboembolism in acutely ill	10
observed in patients with	10
thromboprophylaxis in acutely ill	10
were no significant differences	10
review of all patients	10
venous thromboembolism in acutely	10
patients hospitalized with covid	10
assessment model for the	10
presented to the emergency	10
have been reported in	10
on the day of	10
median age was years	10
was no significant difference	10
a cohort of patients	10
the use of a	10
in the majority of	10
patient was started on	10
on the use of	10
has been described in	10
in the critically ill	10
study is needed to	10
diagnosis and treatment of	10
this was a retrospective	10
patients with acute ischemic	10
with the addition of	10
this is a retrospective	10
as part of the	10
hospital length of stay	10
prevention of vte in	10
the course of the	10
creatinine clearance ml min	10
graft versus host disease	10
for the development of	10
thromboembolism in critically ill	10
chart review was performed	10
safety and efficacy of	10
accepted article this article	10
the proportion of patients	10
an academic hospital in	10
course was complicated by	10
to an academic hospital	10
a major cause of	10
and young adults with	10
article this article is	10
of a patient with	10
standard of care for	10
in patients with coronavirus	10
for critically ill patients	10
pediatric and young adult	10
this study aims to	10
of coronavirus disease in	9
of disseminated intravascular coagulation	9
considered in patients with	9
in the pathogenesis of	9
scientific and standardization committee	9
with a mean age	9
are at risk for	9
conducted a retrospective chart	9
a high risk of	9
with a median of	9
most common cause of	9
the primary outcome was	9
no statistically significant difference	9
coronavirus disease in china	9
the electronic medical record	9
incidence of venous thromboembolic	9
the vast majority of	9
for hospitalized and nonhospitalized	9
intensive care unit for	9
signs and symptoms of	9
from january to december	9
and nonhospitalized medical patients	9
hospitalized and nonhospitalized medical	9
for a total of	9
has not been studied	9
for patients with a	9
been shown to be	9
in patients with sepsis	9
prophylaxis for hospitalized and	9
of vte in hospitalized	9
patients who did not	9
of venous thromboembolic events	9
sensitivity and specificity of	9
the patient was started	9
cell acute lymphoblastic leukemia	9
between the two groups	9
at a single institution	9
further studies are needed	9
thromboembolic events in anticoagulated	9
the leading cause of	9
in accordance with the	9
during the course of	9
patients with severe sars	9
in acute ischemic stroke	9
the american society of	9
severe traumatic brain injury	9
in anticoagulated severe covid	9
the prevalence of vte	9
venous thromboembolism in critically	9
reduce the risk of	9
in patients with sickle	9
among hospitalized patients with	9
of the international society	9
events in anticoagulated severe	9
we sought to determine	9
in acutely ill hospitalized	9
high incidence of venous	9
a high incidence of	9
a case series of	9
in patients with high	9
in the intensive care	9
adolescents and young adults	9
were admitted to the	9
patients were included in	9
patients infected with covid	9
did not differ between	9
in medical patients with	9
no significant difference in	9
a rare case of	9
with a median follow	9
hospitalization for medical illness	8
was approved by the	8
the study will be	8
increase the risk of	8
regarding the use of	8
may be due to	8
rates of vte in	8
european society of cardiology	8
features of patients infected	8
italian society on thrombosis	8
a high rate of	8
decision was made to	8
can be used to	8
is a major cause	8
novel coronavirus in wuhan	8
of the patients had	8
clinical features of patients	8
after hospitalization for medical	8
of the american college	8
are more likely to	8
on the presence of	8
pediatric hematology oncology fellowship	8
the development of a	8
a pediatric patient with	8
and are associated with	8
past medical history of	8
at the discretion of	8
have been shown to	8
were significantly associated with	8
old male with a	8
in patients with atrial	8
of the study is	8
in the case of	8
with acute lymphoblastic leukemia	8
in pediatric oncology patients	8
in patients with sars	8
pediatric patients with scd	8
of patients treated with	8
patients in intensive care	8
course of the study	8
further study is needed	8
of patients in the	8
the ochsner health system	8
a report of the	8
guidelines for the diagnosis	8
old female presented with	8
vte in hospitalized covid	8
admitted to our hospital	8
pediatric intensive care unit	8
this case highlights the	8
a high prevalence of	8
to the development of	8
report of the american	8
with novel coronavirus in	8
risk of major bleeding	8
at high risk of	8
with no evidence of	8
baylor college of medicine	8
in patients who are	8
infected with novel coronavirus	8
within hours of admission	8
a subset of patients	8
are associated with a	8
rate of vte in	8
patients with ischemic stroke	8
the risk of bleeding	8
and was found to	8
as well as a	8
may be considered in	8
was significantly associated with	8
patients were treated with	8
of these patients had	8
has the potential to	8
these findings suggest that	8
of patients with scd	8
associated with an increased	8
had at least one	8
before and after the	8
children and young adults	8
and venous thromboembolism in	8
of pediatric patients with	8
study was to evaluate	8
the european society of	8
we describe a case	8
patients infected with novel	8
number of patients with	8
our objective was to	8
thrombosis and pulmonary embolism	8
are at risk of	8
a high index of	8
of children with cancer	8
patients who are not	8
study is to evaluate	8
was higher in the	8
year old female with	8
of low molecular weight	7
icu length of stay	7
caused by the severe	7
case report of a	7
with aneurysmal subarachnoid hemorrhage	7
an increase in the	7
of patients who underwent	7
between january and june	7
elevated in patients with	7
with acute respiratory distress	7
guideline for the management	7
has not been well	7
vte in nonsurgical patients	7
of severe acute respiratory	7
work is needed to	7
in intensive care unit	7
there was a significant	7
incidence of pulmonary embolism	7
due to lack of	7
other parameters of hemostasis	7
morbidity and mortality in	7
of patients with vte	7
therapy during the covid	7
thromboelastography findings and other	7
after adjusting for age	7
this study sought to	7
continuous renal replacement therapy	7
performed a retrospective review	7
at risk for vte	7
in the care of	7
and other parameters of	7
patients admitted to icu	7
antibodies in patients with	7
survivors of cardiac arrest	7
anticoagulant therapy during the	7
based on the presence	7
developed in collaboration with	7
was associated with lower	7
management of these patients	7
for at least months	7
we report the first	7
retrospective review of all	7
case of a patient	7
were found to be	7
included in the analysis	7
between the ages of	7
in the united kingdom	7
with at least one	7
was no statistically significant	7
an intensive care unit	7
from the anticoagulation forum	7
antiphospholipid antibodies in patients	7
all patients with covid	7
in all patients with	7
management of acute pulmonary	7
for the diagnosis of	7
deep vein thrombosis and	7
an important role in	7
acutely ill hospitalized patients	7
in patients with pe	7
venous thromboembolism in the	7
international medical prevention registry	7
between march and may	7
by the world health	7
a significant proportion of	7
of patients with a	7
peking union medical college	7
a report of thromboelastography	7
there was no statistically	7
interim clinical guidance from	7
the cumulative incidence of	7
presented to the ed	7
there is limited data	7
total of patients with	7
during their hospital stay	7
study was approved by	7
treatment and prevention of	7
the decision was made	7
it is reasonable to	7
a randomized controlled trial	7
she was treated with	7
a significant reduction in	7
at the site of	7
retrospective study of patients	7
severe acute respiratory distress	7
the pediatric intensive care	7
antithrombotic therapy for vte	7
medical prevention registry on	7
of a year old	7
associated with increased mortality	7
in those patients who	7
the high risk of	7
he was treated with	7
in children with sickle	7
clinical guidance from the	7
guidance from the anticoagulation	7
on the other hand	7
outcomes of patients with	7
proximal dvt or pe	7
with the exception of	7
patients with severe ncp	7
patients aged or older	7
will be conducted in	7
acute ischemic stroke patients	7
was admitted to the	7
with an increased risk	7
primary objective was to	7
of pulmonary embolism in	7
practical guidance for the	7
the standard of care	7
by the severe acute	7
prior to the start	7
a case report of	7
patients met inclusion criteria	7
it is possible that	7
the safety and efficacy	7
for at least days	7
posterior reversible encephalopathy syndrome	7
for patients with covid	7
was used to determine	7
in the present study	7
increases the risk of	7
and antiphospholipid antibodies in	7
coagulopathy and antiphospholipid antibodies	7
case of a year	7
were excluded from the	7
of vte in nonsurgical	7
for all patients with	7
prophylaxis in acutely ill	7
patients with proximal dvt	7
who were treated with	7
is the first case	7
associated acute respiratory distress	7
is to evaluate the	7
a significant decrease in	7
the time of diagnosis	7
findings and other parameters	7
with traumatic brain injury	7
patients were diagnosed with	7
results of this study	7
of thromboelastography findings and	7
years of age with	7
and anticoagulant therapy during	7
and management of acute	7
at high risk for	7
in out of patients	7
who presented to the	7
is associated with increased	7
is caused by the	7
with proximal dvt or	7
be considered in the	7
chart review was conducted	7
there was no evidence	7
retrospective review of patients	7
therapy for vte disease	7
risk for vte and	7
clinicians may wish to	7
report of thromboelastography findings	7
may wish to consider	7
acute pulmonary embolism and	7
median survival of days	6
are needed to confirm	6
of patients with acute	6
and clinical characteristics of	6
the occurrence of vte	6
at the same time	6
was no evidence of	6
median age at diagnosis	6
risk factors for venous	6
is the number of	6
conducted a retrospective review	6
by recent laboratory test	6
assess the impact of	6
guidance for the prevention	6
within the first hours	6
decreased in and increased	6
the median age at	6
aged years or older	6
the course of months	6
atypical hemolytic uremic syndrome	6
higher risk for vte	6
association task force on	6
a bone marrow aspirate	6
on the surface of	6
of thrombosis and management	6
in the outpatient setting	6
between january and december	6
survival to hospital discharge	6
statistically significant difference in	6
in the process of	6
with standard hygiene requirements	6
thrombosis and management of	6
is common in patients	6
survival among hospitalized patients	6
blood coagulation of patients	6
high risk for vte	6
pulmonary embolism and covid	6
treatment dose anticoagulation with	6
he was started on	6
of these patients were	6
optic nerve sheath diameter	6
pattern of patients with	6
to determine the incidence	6
prospective studies are needed	6
a total of children	6
a prospective observational study	6
in patients with cancer	6
the primary endpoint was	6
these findings support the	6
was calculated for each	6
high levels of d	6
association of treatment dose	6
prominent changes in blood	6
external validation of the	6
severe profound hearing loss	6
prevention of thrombosis and	6
vitro and in vivo	6
as well as other	6
factors for venous thromboembolism	6
the rate of vte	6
care unit for acute	6
ill medical patients with	6
in sickle cell disease	6
acute pulmonary embolism in	6
our data suggest that	6
for medical patients in	6
compared to those with	6
the versatile heparin in	6
days after hospital admission	6
quality of life and	6
confirmed by recent laboratory	6
a higher rate of	6
lopinavir ritonavir or atazanavir	6
test was used to	6
when compared to the	6
with altered mental status	6
old male presented with	6
prior to initiation of	6
clinical guidance on the	6
the goal of this	6
intravascular coagulation of patients	6
a role in the	6
the use of mechanical	6
young adult patients with	6
with an increase in	6
play a role in	6
withdrawal of life support	6
prevention registry on venous	6
heart association task force	6
significant difference in the	6
management of coagulopathy and	6
coagulation of patients infected	6
thrombosis in hospitalized patients	6
ill hospitalized patients with	6
patients aged years or	6
cause of death and	6
duration of mechanical ventilation	6
neurosciences intensive care unit	6
of the patients in	6
the end of induction	6
if the patient is	6
the treatment of acute	6
study of patients with	6
the international medical prevention	6
identify hospitalized medical patients	6
the prevention of thrombosis	6
retrospective analysis of patients	6
the use of oral	6
evaluate the effect of	6
old female with a	6
significantly higher in the	6
h car t cells	6
vein thrombosis and pulmonary	6
of a patient who	6
prophylaxis in medical patients	6
age at time of	6
of patients who received	6
of coagulopathy and disseminated	6
pediatric patients with sickle	6
in collaboration with the	6
leading cause of death	6
the proportion of protocols	6
and major thromboembolic events	6
between vte and non	6
after traumatic brain injury	6
of the international medical	6
vein thrombosis in patients	6
and days of enrolment	6
national institutes of health	6
outcome in patients with	6
we sought to describe	6
disseminated intravascular coagulation of	6
patient is a year	6
were used to compare	6
have been associated with	6
in blood coagulation of	6
and quality of life	6
are needed to determine	6
is the first report	6
the total number of	6
changes in blood coagulation	6
high rate of vte	6
to intensive care unit	6
in icu patients with	6
been associated with a	6
for patients who received	6
after the start of	6
patients who present with	6
length of hospital stay	6
in patients who had	6
american heart association task	6
end of the study	6
male with a history	6
in a child with	6
and associative models to	6
determine the prevalence of	6
at the study center	6
were compared between the	6
coagulation of patients with	6
a prior history of	6
nonhospitalized patients with covid	6
with severe acute respiratory	6
hematology oncology fellowship programs	6
of treatment dose anticoagulation	6
the average number of	6
any hospitalization or all	6
these patients should be	6
vte and bleeding risk	6
guidance on the diagnosis	6
is based on the	6
in order to reduce	6
has been reported to	6
does not appear to	6
inclusion and exclusion criteria	6
proportion of protocols that	6
it is difficult to	6
in and increased in	6
of patients with severe	6
regression was used to	6
associative models to identify	6
the duration of the	6
and young adult patients	6
versatile heparin in covid	6
incidence of vte was	6
models to identify hospitalized	6
associated with a lower	6
at months of age	6
in all hospitalized patients	6
no conflicts of interest	6
to intensive care with	6
likely to have a	6
influenza a h n	6
were less likely to	6
pulmonary thrombosis in covid	6
the results of the	6
in an effort to	6
statistics were used to	6
to assess the impact	6
the most common cause	6
fatal and major thromboembolic	6
in view of the	6
higher incidence of vte	6
cumulative incidence of vte	6
thromboembolism and anticoagulant therapy	6
procoagulant pattern of patients	6
patients in a tertiary	6
a position paper from	6
studies have shown that	6
anticoagulation in patients with	6
with the risk of	6
common in patients with	6
plays an important role	6
not associated with increased	6
predictive and associative models	6
of patients had a	6
for thromboprophylaxis in acutely	6
times more likely to	6
as a marker of	6
in patients treated with	6
embolism in patients with	6
rare case of a	6
and the use of	6
block group poverty status	6
from symptom onset to	6
in patients with asah	6
in patients who received	6
to the start of	6
who were admitted to	6
to identify hospitalized medical	6
prophylaxis in critically ill	6
to have a higher	6
and vte prophylaxis for	6
to determine the prevalence	6
under years of age	6
associated with worse outcomes	6
risk factor for vte	6
of patients with sars	6
infected pneumonia in wuhan	6
registry on venous thromboembolism	6
in vitro and in	6
with lmwh or fondaparinux	6
highlights the need for	6
median age of years	5
the international classification of	5
in children with cancer	5
a teaching hospital in	5
be used as a	5
will be used for	5
incidence of vte among	5
a strong predictor of	5
is the author funder	5
of the clinical trial	5
mean age of patients	5
white blood cell and	5
cohort of patients with	5
multivariable logistic regression analysis	5
enrolled in the study	5
a significant increase in	5
to severe acute respiratory	5
risk factors for thrombosis	5
first reported case of	5
a prospective cohort study	5
has granted medrxiv a	5
for acute ischemic stroke	5
and the lack of	5
of acute ischemic stroke	5
research should focus on	5
who has granted medrxiv	5
admitted to the neurocritical	5
were admitted to our	5
performed a retrospective analysis	5
features between severe pneumonia	5
and standardization committee communication	5
we were able to	5
increase in major bleeding	5
to the fact that	5
novel coronavirus pneumonia incidence	5
difference of coagulation features	5
of patients hospitalized for	5
in the number of	5
patients were more likely	5
aimed to evaluate the	5
is associated with higher	5
in the two groups	5
novel coronavirus pneumonia in	5
it remains unclear whether	5
patients with a diagnosis	5
tm ews fli type	5
the procoagulant pattern of	5
for acute respiratory failure	5
showed no evidence of	5
a statistically significant increase	5
presence of a school	5
are less likely to	5
this version posted may	5
holder for this preprint	5
that the presence of	5
in the first year	5
the risk of venous	5
of vte among patients	5
the median age was	5
children with advanced cancer	5
in patients with tbi	5
be considered for patients	5
of thrombosis and haemostasis	5
factors in patients with	5
venous thromboembolism associated with	5
is associated with poor	5
included in this study	5
met the inclusion criteria	5
the recommendation to use	5
the development of epilepsy	5
the first reported case	5
hospitalized patients with coronavirus	5
characteristics of hospitalized patients	5
old female who presented	5
a neurologist or neurosurgeon	5
be associated with a	5
time to enteral antihypertensive	5
patients with brain injury	5
no later than calendar	5
license to display the	5
can lead to a	5
of novel coronavirus pneumonia	5
risk assessment model of	5
compared to those who	5
for patients with scd	5
in patients presenting with	5
thromboprophylaxis in patients with	5
related severe hypercoagulability in	5
as part of a	5
to the risk of	5
model of the international	5
high morbidity and mortality	5
cohort study pulmonary embolism	5
in the general population	5
hospital survival among hospitalized	5
a cumulative incidence of	5
the preprint in perpetuity	5
pulmonary embolism or pulmonary	5
the risk assessment model	5
was successfully treated with	5
certainty in the evidence	5
of acute kidney injury	5
from the electronic medical	5
of dual antiplatelet therapy	5
to an intensive care	5
and health systems during	5
of a pediatric patient	5
investigator is responsible for	5
the first months of	5
likely to be discharged	5
in the most severe	5
should be monitored closely	5
admitted to the neuro	5
in patients at high	5
is a rare autosomal	5
and review of the	5
medical patients in a	5
warfarin in patients with	5
the differential diagnosis of	5
at years of age	5
hypercoagulability in patients admitted	5
which can lead to	5
the role of the	5
end of life care	5
the university of cincinnati	5
the primary objective of	5
of acute lymphoblastic leukemia	5
were not significantly different	5
patients with tbi and	5
medrxiv a license to	5
agree or strongly agree	5
of venous and arterial	5
patients with creatinine clearance	5
in the immediate post	5
of coagulation features between	5
cd t cells and	5
which this version posted	5
been shown to improve	5
given the risk of	5
or pulmonary thrombosis in	5
reduce the incidence of	5
dose anticoagulation with in	5
with a higher risk	5
that there is a	5
epidemiological and clinical characteristics	5
later than calendar days	5
not been well studied	5
packed red blood cell	5
a past medical history	5
for vte and bleeding	5
many of these patients	5
as soon as possible	5
been reported to be	5
academic hospital in incidence	5
admitted to an intensive	5
and management of patients	5
in a subset of	5
assessment of venous thromboembolism	5
the number of patients	5
in pediatric and young	5
associated with the presence	5
patients with a positive	5
an increase in d	5
characteristics and outcomes of	5
risks and benefits of	5
of vte in this	5
the left lower lobe	5
was to evaluate the	5
unit for acute respiratory	5
a platelet count of	5
is a year old	5
hospital in the united	5
vte prophylaxis for nonhospitalized	5
and activated partial thromboplastin	5
the high prevalence of	5
hospitalized medically ill patients	5
the copyright holder for	5
to prevent vte in	5
during the coronavirus disease	5
an external ventricular drain	5
has not been reported	5
case of a pediatric	5
to better understand the	5
in patients diagnosed with	5
is thought to be	5
clinical characteristics of hospitalized	5
prophylaxis and vte prophylaxis	5
patients were excluded if	5
study will be conducted	5
if no contraindication exists	5
intensive care with covid	5
a review of the	5
but there was no	5
our findings suggest that	5
in a variety of	5
complications of patients admitted	5
between severe pneumonia induced	5
did not identify any	5
in the evidence of	5
rivaroxaban for thromboprophylaxis in	5
patients with aneurysmal subarachnoid	5
for patients who are	5
have a role in	5
index of suspicion for	5
be considered in all	5
display the preprint in	5
critically ill medical patients	5
been found to be	5
outcome was defined as	5
the diagnosis of pe	5
of one or more	5
validation of the risk	5
of patients were included	5
teaching hospital in the	5
clinical characteristics of cases	5
in the form of	5
high incidence of vte	5
adolescent and young adult	5
mean age was years	5
esc guidelines for the	5
certified by peer review	5
the patient continued to	5
there may be a	5
lower in patients with	5
has been previously reported	5
have been used for	5
against the use of	5
was used to compare	5
medical outpatients with minor	5
not significantly associated with	5
pneumonia induced by sars	5
low certainty in the	5
low risk of bleeding	5
there are currently no	5
to display the preprint	5
is the recommendation to	5
and days of randomization	5
significant difference was found	5
coagulation features between severe	5
adult patients with scd	5
to evaluate the efficacy	5
a retrospective study of	5
who did not have	5
these data suggest that	5
acute ischemic stroke and	5
patients with lvh on	5
pulmonary embolism in patients	5
reduces the risk of	5
the neurocritical care society	5
the high incidence of	5
of this project was	5
high prevalence of asymptomatic	5
the patients who were	5
in the pe group	5
position paper from italian	5
high cumulative incidence of	5
highlights the importance of	5
is associated with high	5
american college of chest	5
only in patients with	5
novel coronavirus pneumonia clinical	5
in the final analysis	5
of cases of novel	5
the risk of major	5
a logistic regression model	5
cases of novel coronavirus	5
coronavirus pneumonia incidence of	5
patients with a bmi	5
adjusting for age and	5
characteristics of cases of	5
any of the following	5
was associated with increased	5
are independently associated with	5
year efs and os	5
with high levels of	5
and traumatic brain injury	5
the patients in the	5
an early clamp trial	5
s of s background	5
the median age of	5
east respiratory syndrome coronavirus	5
patients with traumatic brain	5
been shown to have	5
to the severity of	5
severe hypercoagulability in patients	5
a part of the	5
were associated with a	5
with the presence of	5
compared to patients without	5
san matteo hospital foundation	5
on the basis of	5
can be used as	5
of the risk assessment	5
recommendation to use high	5
of patients diagnosed with	5
by the use of	5
primary objective of this	5
to the university of	5
study was designed to	5
cause of death in	5
the pathogenesis of vte	5
and no later than	5
is needed to determine	5
neutrophil extracellular traps in	5
the incidence of symptomatic	5
patients and those with	5
current standard of care	5
for venous thromboembolism in	5
in a series of	5
to evaluate the safety	5
are at high risk	5
findings and venous thromboembolism	5
had a history of	5
in the past months	5
cardiovascular considerations for patients	5
hospitalized with severe covid	5
a license to display	5
analysis was performed to	5
thrombotic complications of patients	5
length of stay was	5
the clinical course of	5
associated with an increase	5
had a diagnosis of	5
part of the study	5
the management of these	5
at higher risk for	5
she was diagnosed with	5
peak plasma igf levels	5
mri of the brain	5
factors for vte and	5
a direct oral anticoagulant	5
a higher prevalence of	5
granted medrxiv a license	5
the time of admission	5
prophylaxis for nonhospitalized patients	5
with acute medical illness	5
known risk factors for	5
who were diagnosed with	5
study was to determine	5
autopsy findings and venous	5
were excluded if they	5
of all patients who	5
hospitalized patients with novel	5
patients with at least	5
at a teaching hospital	5
could be used to	5
the use of lmwh	5
shrna tm ews fli	5
ultrasonography of the legs	5
associated with a worse	5
was present in patients	5
in a tertiary health	5
prevalence of asymptomatic dvt	5
was significantly lower in	5
a tertiary health system	5
we were unable to	5
therapy can be used	5
of randomized controlled trials	5
with fever and neutropenia	5
dimer and fibrinogen levels	5
with primary diagnosis of	5
into the risk of	5
thromboprophylaxis in medically ill	5
with a past medical	5
of the patients included	5
there has been no	5
not certified by peer	5
was associated with poor	5
of middle east respiratory	5
major cause of morbidity	5
severe pneumonia induced by	5
in a significant proportion	5
used in patients with	5
asymptomatic deep vein thrombosis	5
pulmonary and cardiac pathology	5
was a retrospective chart	5
confirming the diagnosis of	5
of a total of	5
coronavirus pneumonia in wuhan	5
addressed a clinical question	5
college of chest physicians	5
future research should focus	5
in these patients and	5
may be considered for	5
has been demonstrated to	5
comparison of enoxaparin with	5
risk in patients with	5
to reduce the risk	5
the median time from	5
as a predictor of	5
in a pediatric patient	5
paper from italian society	5
embolism or pulmonary thrombosis	5
hospital in incidence of	5
months after initiation of	5
thromboprophylaxis after hospitalization for	5
the setting of acute	5
at time of diagnosis	5
of the primary efficacy	5
the percentage of patients	5
copyright holder for this	5
is a rare but	5
patients hospitalized in the	5
our aim was to	5
the diagnosis of vte	5
systems during the coronavirus	5
for deep vein thrombosis	5
bone marrow evaluation showed	5
as well as in	5
an average age of	5
from italian society on	5
this project was to	5
heparin for thromboprophylaxis justified	5
the first report of	5
a total of days	5
especially in critically ill	5
evaluate the efficacy of	5
the management of covid	5
role in the development	5
and cardiac pathology in	5
health systems during the	5
we retrospectively reviewed the	5
the use of doacs	5
was not certified by	5
this study aimed to	5
dose heparin for thromboprophylaxis	5
were used to evaluate	5
assessment model of the	5
deep venous thrombosis in	5
an increased incidence of	5
the mean age of	5
major clinically relevant bleeding	5
for the study of	5
study aims to describe	4
january and june regarding	4
the authors of this	4
therapy for treatment of	4
is in line with	4
a median survival of	4
review of patients admitted	4
in patients with mechanical	4
of patients presenting with	4
if evaluated as suspected	4
significant morbidity and mortality	4
red blood cell alloimmunization	4
data was collected to	4
induction day for pt	4
medical patients with recently	4
in those who did	4
of fatal outcomes of	4
and clinical characteristics were	4
the incidence of dvt	4
negative predictive value was	4
the risk for vte	4
required elements of informed	4
to provide additional information	4
were included in this	4
mortality in hospitalized patients	4
data was collected over	4
be conducted in the	4
evaluate the safety and	4
needed in order to	4
and an increase in	4
of the following events	4
acute pulmonary embolism associated	4
food and drug administration	4
in the clinical setting	4
a common complication in	4
patients with ketosis prone	4
more likely to require	4
of hematopoietic stem cell	4
empirical systemic anticoagulation is	4
excluded from the study	4
the time of discharge	4
saes if evaluated as	4
cultures in patients with	4
meier estimated day survival	4
decreased venous thromboembolism in	4
and their impact on	4
risk factors such as	4
medical records of patients	4
registry between january and	4
decreased in out of	4
critically ill influenza a	4
placebo for the prevention	4
with ketosis prone diabetes	4
china clinical course and	4
patients diagnosed with covid	4
median and interquartile range	4
treatment of patients with	4
embolism developed in collaboration	4
the use of vte	4
provided in the study	4
in patients with poor	4
not be sufficient to	4
has yet to be	4
mean and standard deviation	4
series of two patients	4
appeared to be associated	4
alone or in combination	4
with a worse prognosis	4
in children and young	4
vte prophylaxis and vte	4
the records of the	4
a consensus statement before	4
by the end of	4
in the acute phase	4
were diagnosed with vte	4
have been implicated in	4
at a single center	4
we found that the	4
at low risk for	4
children with scd and	4
in the diagnosis of	4
to participate in the	4
the closest study center	4
more than of patients	4
to improve patient outcomes	4
a modified version of	4
to the neurocritical care	4
as a potential therapeutic	4
novel coronavirus pneumonia covid	4
memorial sloan kettering cancer	4
of asymptomatic deep vein	4
are the most common	4
can be used for	4
among patients with covid	4
is characterized by a	4
cell count and ischemic	4
for nonhospitalized patients with	4
ranked th out of	4
no significant interaction between	4
with absent n s	4
patient with hyper ige	4
not included in the	4
a h n acute	4
to reduce the incidence	4
examine the relationship between	4
the patients with a	4
duration of transgression was	4
recommend the use of	4
data was collected on	4
patients with acute medical	4
with sickle cell anemia	4
of the study will	4
b t m significantly	4
days following awareness that	4
patients treated with antiviral	4
by global blood therapeutics	4
pulmonary embolism developed in	4
given the rarity of	4
had higher rates of	4
less likely to have	4
has been suggested that	4
these results suggest that	4
months of age with	4
extremity deep venous thrombosis	4
antithrombotic and thrombolytic therapy	4
of tissue plasminogen activator	4
patient is a yo	4
and two large cantonal	4
that event meets criteria	4
jugular bulb venous monitoring	4
to be effective in	4
the accuracy of the	4
to determine if there	4
than calendar days following	4
person from the same	4
quality improvement project was	4
in the hours post	4
of the prothrombin time	4
it is important for	4
may be related to	4
involved in the care	4
with hyper ige syndrome	4
systemic anticoagulation is associated	4
and the presence of	4
of the use of	4
in patients affected by	4
a potential therapeutic target	4
randomized controlled trials are	4
autopsy series from new	4
was started on a	4
awareness that event meets	4
in the icu and	4
risk factors and outcomes	4
patients with a history	4
and peak plasma igf	4
diagnosis of venous thromboembolism	4
the small sample size	4
the urgent need for	4
significantly lower in patients	4
number of significant genes	4
the high cumulative incidence	4
of acute respiratory distress	4
case series of patients	4
are not aware of	4
statistical analysis was performed	4
a case in which	4
compromised t cell immunity	4
due to the risk	4
there is an urgent	4
electronic medical records of	4
and may serve as	4
review was performed on	4
with r r b	4
the time of evd	4
use of dual antiplatelet	4
on how to administer	4
the negative predictive value	4
a lower risk of	4
the emergency department with	4
of vte in critically	4
are at low risk	4
should be paid to	4
is insufficient data to	4
and did not receive	4
of bleeding in patients	4
an accompanying person from	4
appear to be a	4
were collected from patients	4
the ovid study will	4
present at the time	4
care practices involving the	4
the medical records of	4
patients were started on	4
with decreased venous thromboembolism	4
did and did not	4
on a case by	4
calendar days following awareness	4
in patients with leukemia	4
and the negative predictive	4
thrombosis in patients in	4
patients with fever and	4
should be considered as	4
history of previous vte	4
the authors have declared	4
appears to be a	4
patients that did not	4
this retrospective observational study	4
more likely to develop	4
did not receive anticoagulation	4
and in patients with	4
potential conflicts of interest	4
of vte in acutely	4
were significantly higher in	4
significantly higher rates of	4
statistically significant differences in	4
of the present study	4
can be considered in	4
compared to patients who	4
is consistent with the	4
to determine the impact	4
was only significant for	4
pulmonary embolism in a	4
was the most frequent	4
college of cardiology american	4
to determine if the	4
up to of patients	4
our hypothesis is that	4
of vte in the	4
at the onset of	4
ischemic stroke patients with	4
in patients with non	4
used in the treatment	4
at high bleeding risk	4
critically ill patient with	4
symptom onset to recanalization	4
a case by case	4
can be used after	4
the local organ procurement	4
anticoagulation is associated with	4
but was associated with	4
with moderate to severe	4
in patients hospitalized for	4
a unique case of	4
recommended in patients with	4
coagulopathy and venous thromboembolism	4
versus warfarin in patients	4
increase in severe covid	4
who are at low	4
of three patients with	4
those with and without	4
is a case report	4
of this study are	4
of the incidence of	4
ng ml at hours	4
all patients who received	4
the use of ufh	4
to the hospital with	4
cumulative incidence of thrombotic	4
is needed to understand	4
in a logistic regression	4
unexpected and drug related	4
declare that they have	4
acute graft versus host	4
postdischarge vte prophylaxis and	4
patients with severe disease	4
should be strongly considered	4
in the last years	4
adjusted for age and	4
the discretion of the	4
this study will be	4
ambulatory patients aged or	4
the time of hospital	4
authors declare that they	4
in a total of	4
this retrospective study was	4
that they have no	4
the acute management of	4
in a young patient	4
were used to assess	4
of ufh or lmwh	4
any time in the	4
of mortality due to	4
ii and sofa scores	4
pediatric patients with cancer	4
cardiology american heart association	4
case by case basis	4
no potential conflicts of	4
mg subcutaneously every hours	4
may serve as a	4
patients were admitted to	4
participation in the study	4
syndrome patients treated with	4
the start of treatment	4
closely related to the	4
the most common diagnosis	4
due to severe acute	4
within the normal range	4
patients may benefit from	4
a cohort of covid	4
within hours of arrival	4
of venous thromboembolism risk	4
incidence of symptomatic osteonecrosis	4
with the development of	4
a new york city	4
lost to follow up	4
report of a patient	4
to evaluate the association	4
to the high risk	4
the recommended dose of	4
higher white blood cell	4
did not appear to	4
we identified patients who	4
the effects of altemiatm	4
accompanying person from the	4
the diagnosis of dvt	4
those who were not	4
was lower in patients	4
further work is needed	4
the pediatric oncology population	4
the management of pediatric	4
age at diagnosis was	4
described in the literature	4
our objective is to	4
obese patients with ischemic	4
there is insufficient data	4
a copy of the	4
of refractory status epilepticus	4
of hlh in a	4
this retrospective chart review	4
acute pulmonary embolism developed	4
at our institution over	4
are associated with increased	4
we report a patient	4
of delayed cerebral ischemia	4
in ambulatory patients with	4
cardiac injury with mortality	4
of these patients in	4
that the number of	4
patients should be monitored	4
primary and metastatic wt	4
tested positive for sars	4
in these patients is	4
patients who had been	4
the american heart association	4
a diagnosis of acute	4
had a statistically significant	4
prevention and management of	4
is a rare disease	4
our institution over a	4
lmwh or fondaparinux over	4
in patients with other	4
of patients who had	4
a significant cause of	4
and a median survival	4
informed consent was obtained	4
associated with coronavirus disease	4
catheter associated urinary tract	4
may be an effective	4
vte in critically ill	4
there is a significant	4
of patients with vascular	4
that patients with covid	4
the implementation of a	4
that addressed a clinical	4
to acute respiratory distress	4
of pediatric oncology patients	4
a randomized clinical trial	4
as one of the	4
was performed at the	4
lower extremity deep venous	4
of peking union medical	4
a systematic review of	4
associated with older age	4
g dl and platelet	4
the absence of randomized	4
blood cell count and	4
absence of any contraindications	4
of mechanical ventilation and	4
has emerged as a	4
with mortality in hospitalized	4
patients at high risk	4
a retrospective case series	4
of the local organ	4
in at least one	4
it has been suggested	4
the neurocritical care population	4
in pediatric hematology oncology	4
efficacy of ketamine in	4
are listed in table	4
there is a paucity	4
risk factors in patients	4
higher in patients with	4
risk medically ill patients	4
following awareness that event	4
prevent vte in covid	4
fever in children with	4
is significantly associated with	4
of a school re	4
the patient is a	4
no statistically significant differences	4
enoxaparin with placebo for	4
demographic and clinical variables	4
was more common in	4
is associated with an	4
present a patient with	4
a wide range of	4
the first weeks of	4
in patients who were	4
and intensive care unit	4
adjusting for potential confounders	4
during the first hours	4
temperature on day of	4
a comparison of enoxaparin	4
were performed to assess	4
patients who did and	4
of positive blood cultures	4
with coronavirus disease infection	4
the compromised t cell	4
h k m diffuse	4
due to the lack	4
to have a high	4
the use of anticoagulation	4
receiver operating characteristic curve	4
we present a patient	4
had an evd placed	4
as measured by the	4
patients with newly diagnosed	4
associated with acute respiratory	4
and risk factors in	4
were significantly more likely	4
after aneurysmal subarachnoid hemorrhage	4
parents of children with	4
the natural history of	4
for thromboprophylaxis after hospitalization	4
on aspirin plus clopidogrel	4
the first year of	4
systemic inflammatory response syndrome	4
of neutrophil extracellular traps	4
a rare autosomal recessive	4
two large cantonal hospitals	4
are known to have	4
sought to determine whether	4
the end of life	4
did not have a	4
this study suggests that	4
line or study center	4
with patients and families	4
in the course of	4
urine plasma osmolality ratio	4
this quality improvement project	4
report the first case	4
improve the quality of	4
subjective perceptions of recovery	4
induced nausea and vomiting	4
not been studied in	4
a key role in	4
out of patients with	4
intensive care unit with	4
or full treatment dosing	4
the investigator is responsible	4
as part of their	4
with acute myeloid leukemia	4
patients with severe acute	4
in critically ill influenza	4
can serve as a	4
no significant difference between	4
the absence of a	4
the aim of our	4
thromboembolism prophylaxis in acutely	4
have no conflict of	4
high clinical suspicion for	4
length of stay in	4
standardization committee of the	4
has never been reported	4
ews fli type lpx	4
used as a marker	4
data were collected for	4
was an increase in	4
in the differential diagnosis	4
cardiac pathology in covid	4
with head and neck	4
on thrombosis and hemostasis	4
to patients with covid	4
attention should be paid	4
patients at risk of	4
to evaluate differences in	4
randomization will be performed	4
for children with scd	4
less likely to receive	4
sought to determine the	4
been reported in the	4
extended postdischarge vte prophylaxis	4
the inpatient and outpatient	4
dedicated neurocritical care units	4
low risk for bleeding	4
braf v e mutation	4
of protocols that addressed	4
treated with antiviral agents	4
children with scd is	4
with the help of	4
admitted to the university	4
the routine use of	4
with the records of	4
bone marrow biopsy showed	4
pneumonia incidence of thrombotic	4
we present the first	4
of prospectively collected data	4
to evaluate the effect	4
it is recommended to	4
alveolar damage with severe	4
that is characterized by	4
marrow aspirate and biopsy	4
this is a single	4
who did and did	4
for vte prophylaxis in	4
were independently associated with	4
patients with vascular malformations	4
within days prior to	4
bone marrow aspirate and	4
the treatment of covid	4
analysis was performed using	4
of patients with coronavirus	4
to the pediatric intensive	4
made a complete recovery	4
patients with scd and	4
the number of significant	4
observational studies in epidemiology	4
damage with severe capillary	4
apache ii and sofa	4
with an incidence of	4
were selected from the	4
within days of randomization	4
patients with solid tumors	4
directed physical activity program	4
sequential organ failure assessment	4
of deep venous thrombosis	4
percentage of patients with	4
patients in the icu	4
in aneurysmal subarachnoid hemorrhage	4
is a frequent complication	4
pe in patients with	4
a single dose of	4
kg subcutaneously every hours	4
were enrolled in this	4
fatal outcomes of patients	4
prospective cohort study pulmonary	4
at mg kg day	4
in the patients with	4
be monitored closely for	4
lungs and other organs	4
or fondaparinux over ufh	4
has been found to	4
patients in severe sars	4
with placebo for the	4
computed tomography pulmonary angiography	4
h n acute respiratory	4
vte in acutely ill	4
nf is the number	4
in order to standardize	4
practices involving the home	4
the use of thromboprophylaxis	4
for the primary outcome	4
at any time in	4
of dvt and pe	4
is limited data on	4
not significantly different between	4
due to the high	4
a core group of	4
consensus statement before guidelines	4
goal of this study	4
committee of the international	4
patients who were admitted	4
our study demonstrated that	4
to the use of	4
the presence or absence	4
of enoxaparin with placebo	4
bd registry between january	4
incidence of symptomatic vte	4
and in the immediate	4
the primary endpoint is	4
prior to starting chemotherapy	4
were used to identify	4
to examine the relationship	4
from the medical record	4
in more than of	4
even after adjusting for	4
high rates of vte	4
outpatients with minor provoking	4
which is associated with	4
of red blood cells	4
a multicenter cluster randomized	4
been associated with increased	4
injury with mortality in	4
death in patients with	4
through retrospective chart review	4
involving the home environment	4
medical patients with enoxaparin	4
hours of symptom onset	4
with recently reduced mobility	4
striking increase in severe	4
adult and pediatric patients	4
enoxaparin mg subcutaneously every	4
elements of informed consent	4
was used to identify	4
the study was approved	4
patients included in the	4
on the number of	4
a paucity of data	4
of the patients were	4
records of the local	4
cardiovascular implications of fatal	4
is to describe the	4
to a change in	4
local organ procurement organization	4
the median time to	4
direct oral anticoagulant plasma	4
adult patients admitted to	4
the declaration of helsinki	4
interviews were conducted with	4
measured by the average	4
a reduction in the	4
protocols that addressed a	4
at least one complication	4
when controlling for age	4
analysis of patients admitted	4
and length of stay	4
as adjunctive therapy for	4
was well tolerated and	4
in the nonacog alfa	4
programs around the world	4
be included in the	4
less than years old	4
used to compare the	4
with a total of	4
the use of the	4
bmt as a treatment	4
that the incidence of	4
o f journal pre	4
time to first scpc	4
over a month period	4
embolism associated with covid	4
for pediatric patients with	4
was independently associated with	4
but little is known	4
from the same household	4
degradation products of fibrin	4
retrospective cohort study of	4
of thromboembolic complications in	4
patients with high risk	4
by a neurologist or	4
within hours of symptom	4
a risk factor for	4
a safe and effective	4
confirmation of the high	4
who do not have	4
that the rate of	4
deterioration in these patients	4
sloan kettering cancer center	4
were excluded due to	4
of risk assessment models	4
chart review of the	4
k m diffuse midline	4
is a paucity of	4
the nature of the	4
statistically significant increase in	4
female with a history	4
of cardiology american heart	4
cumulative rate of recurrence	4
there is often a	4
to seek medical attention	4
to be elevated in	4
a wide variety of	4
ml at hours post	4
our goal was to	4
in a case of	4
o o f journal	4
was diagnosed with a	4
the treatment of choice	4
was noted in patients	4
the electronic health record	4
in patients with low	4
to an outside hospital	4
an increase in major	4
the aim of the	4
implications of fatal outcomes	4
with known risk factors	4
a patient with a	4
which is consistent with	4
risk factors associated with	4
to those who did	4
emergency neurological life support	4
patients with recently reduced	4
will be submitted to	4
the neurointensive care unit	4
the mean number of	4
predictors of poor outcome	4
series of three patients	4
at end of induction	4
the primary aim of	4
outcome after traumatic brain	4
of patients with confirmed	4
in the frequency of	4
after adjusting for potential	4
induced coagulopathy and disseminated	4
and years of age	4
at low risk of	4
in those patients with	4
as a treatment option	4
and its implications for	4
in patients in severe	4
institutes of health stroke	4
we sought to identify	4
with severe capillary congestion	4
summarized using descriptive statistics	4
in the bone marrow	4
for all hospitalized patients	4
an increased risk for	4
patients were found to	4
or activated partial thromboplastin	4
this is a prospective	4
ages of and years	4
of pediatric and young	4
was based on the	4
is a marker of	4
allogeneic hematopoietic stem cell	4
on day of admission	4
acutely ill medical inpatients	4
who presented with a	4
clinical suspicion for vte	4
in acute myeloid leukemia	4
the median duration of	4
with a mortality rate	4
was collected over a	4
did not seem to	4
study pulmonary embolism in	4
use of mechanical thromboprophylaxis	4
patients with a median	4
of the high cumulative	4
was noted to be	4
a patient with acute	4
of venous thromboembolism associated	4
of childhood cancer survivors	4
series from new orleans	4
the risk of infection	4
in the incidence of	4
supported by global blood	4
the setting of a	4
critically ill patients in	4
validation of risk assessment	4
fatal saes if evaluated	4
the primary objective was	4
safety and tolerability of	4
of all patients with	4
found to be significantly	4
respiratory syndrome patients treated	4
wilcoxon rank sum test	4
we did not find	4
associated with decreased venous	4
n acute respiratory distress	4
demographic and clinical characteristics	4
the current standard of	4
series of patients with	4
of death and disability	4
occurring within days of	4
of a direct oral	4
wide multifaceted quality improvement	4
present the case of	4
and bleeding risk assessments	4
the most severe cases	4
of cardiac injury with	4
the most common solid	4
regulated when compared with	4
hospitals and two large	4
with low molecular weight	4
patients with severe sepsis	4
j thromb haemost doi	4
patient did not have	4
the ages of and	4
presence or absence of	4
need for invasive procedures	4
over a period of	4
of health stroke scale	4
of observational studies in	4
event meets criteria for	4
improvement project was to	4
in order to provide	4
in patients who died	4
in the left lower	4
thromboembolism associated with coronavirus	4
did not receive any	4
is the first to	4
electronic medical records with	4
to the diagnosis of	4
patients who received anticoagulation	4
we hypothesized that the	4
in a median of	4
due to the fact	4
there were no differences	4
prophylaxis for venous thromboembolism	4
in medical and surgical	4
medical records of all	4
have a poor prognosis	4
patients with r r	4
and the need for	4
the absence of any	4
was to determine the	4
blood cell and platelet	4
prolongation of the prothrombin	4
early clamp trial approach	4
there were significant differences	4
medical records with the	4
to identify predictors of	4
patients with objectively confirmed	4
a diagnosis of exclusion	4
patient was diagnosed with	4
thromboembolism in hospitalized medical	4
have been identified in	4
prophylaxis after hospital discharge	4
or in combination with	4
less likely to be	4
the central nervous system	4
of vte in non	4
hospitalization for heart failure	4
and negative predictive value	4
is a known complication	4
children with newly diagnosed	4
admitted to our institution	4
a common cause of	4
in addition to the	4
a substantial number of	4
in the critical care	4
for all patients who	4
records with the records	4
of patients who were	4
by the presence of	4
may be able to	4
association of cardiac injury	4
hospitalized acutely ill medical	4
were obtained from the	4
with a decrease in	4
rivaroxaban for thromboprophylaxis after	4
associated with poor outcome	4
is known to be	4
aim of our study	4
included in the final	4
the present study was	4
risk for vte than	4
cl care practices involving	4
needed to determine the	4
the need for further	4
patient who did not	4
ill influenza a h	4
mg kg subcutaneously every	4
criteria for a susar	4
to the lack of	4
all patients with vte	4
a significant difference in	4
to the presence of	4
in the literature of	4
at the recommended dose	4
this was a single	4
should not be considered	4
with past medical history	4
systematic review of the	4
to be related to	4
pulmonary embolism associated with	4
have a higher incidence	4
initial and peak plasma	4
diffuse alveolar damage with	4
two years of age	3
the experimental group as	3
with resolution of symptoms	3
in the study by	3
support the use of	3
in temperature on day	3
a normal ejection fraction	3
occurred in of patients	3
therapy has been shown	3
calculated using the cockcroft	3
management of disseminated intravascular	3
patients who are at	3
old female with history	3
the optimal management of	3
than the general population	3
of symptomatic vte is	3
large academic medical center	3
admitted to a tertiary	3
controlled trial of dalteparin	3
religious beliefs and practices	3
the johns hopkins hospital	3
case reports and case	3
biopsy was performed which	3
patient was treated with	3
an association with dvt	3
we report a rare	3
pathological evidence of pulmonary	3
to our hospital with	3
it has never been	3
treatment or lack of	3
female who presented with	3
posing an indication for	3
respiratory distress syndrome patients	3
the enrolment of the	3
novel viral disease characterized	3
for the use of	3
study aimed to evaluate	3
research into the risk	3
outcomes were defined as	3
if the platelet count	3
the context of a	3
at the emergency department	3
anticoagulants in the treatment	3
patients requiring intensive care	3
were newly diagnosed with	3
venous return in the	3
neuro intensive care unit	3
outcome of patients with	3
a clinical audit using	3
of those not enrolled	3
or inability to adhere	3
the context of covid	3
disorders in coronavirus infected	3
significant liver disease associated	3
determine the role of	3
west nile neuroinvasive disease	3
used to determine the	3
with a primary diagnosis	3
time to reach adequate	3
change in temperature on	3
undergoing allohct for myeloid	3
that nonhospitalized patients with	3
patients who had an	3
sample size was fixed	3
objective was to evaluate	3
total of patients who	3
critically ill patients admitted	3
is frequent in patients	3
of t cells and	3
mean length of hospital	3
were associated with higher	3
associated with a poor	3
the study aimed to	3
was outlined on t	3
effects of altemiatm on	3
increasing the dose of	3
any known coagulopathy or	3
is needed to validate	3
aim was to assess	3
the glasgow outcome scale	3
disease severity and mortality	3
our understanding of the	3
than months of age	3
and variegated findings of	3
has been recognized as	3
proportion of patients with	3
all patients who require	3
the favorable outcome group	3
on optimal diagnostic and	3
predisposing strong risk factors	3
meets criteria for a	3
may contribute to the	3
we report a year	3
coronavirus pneumonia clinical characteristics	3
questions and answers on	3
ill patients with neurologic	3
high risk of bias	3
cells l confirmed by	3
higher level of care	3
in multivariate logistic regression	3
spinal cord h k	3
or deep vein thrombosis	3
of covid patients reveals	3
undergoing hematopoietic stem cell	3
patients who require hospital	3
the impact of this	3
the use of empiric	3
in the study and	3
as compared to control	3
or by the patient	3
is a common complication	3
for clinically suspected hypercoagulopathy	3
hemophilia a and b	3
fellowship programs around the	3
we tested the hypothesis	3
prevention of thrombosis antithrombotic	3
pediatric patients with aml	3
mg kg day in	3
been described in adult	3
studies need to be	3
consistent with the applicable	3
is a single center	3
of premature ovarian failure	3
preferred reporting items for	3
the overall prevalence of	3
international classification of diseases	3
thrombotic phenomena in severe	3
with a high rate	3
occurred in a median	3
study of icu patients	3
increase in hematoma volume	3
chemotherapy and radiation therapy	3
patients with cvst who	3
can be treated with	3
half of the patients	3
where proinflammatory cytokines are	3
this study was limited	3
we present the case	3
of pulmonary thrombotic phenomena	3
along with elevated d	3
there were no statistically	3
enoxaparin injections after instructions	3
in the literature in	3
in critically ill children	3
and endotheliitis in covid	3
can be associated with	3
is to determine the	3
retrospective review of a	3
a higher dosage of	3
were selected for literature	3
shown to be effective	3
sickle cell disease is	3
we have developed a	3
a reduction in symptomatic	3
would be associated with	3
in new york city	3
a composite of any	3
the time of neurostimulant	3
values for patients undergoing	3
will be delivered to	3
mainstay of treatment for	3
study aimed to increase	3
abstracted from the electronic	3
not an independent predictor	3
vte in medical patients	3
acute splanchnic vein thrombosis	3
study incidence of thrombotic	3
every hours may be	3
by the local ethics	3
a high level of	3
acute confirmed symptomatic vte	3
risk of vte and	3
caring for patients with	3
the total sample size	3
the x wk group	3
that these patients had	3
in critically ill medical	3
for patients with lvh	3
cause death within days	3
and arterial thrombotic events	3
hypercoagulopathy and microvascular immunothrombosis	3
is an extremely rare	3
study is to describe	3
described in this report	3
were no statistically significant	3
of our study was	3
between hospital admission and	3
at each study center	3
an important cause of	3
by tang and coll	3
models were used to	3
patients with vs without	3
same household also complying	3
with lmwh in pts	3
representation of selected genes	3
be taken into account	3
pulmonary thrombotic phenomena in	3
for patients with tbi	3
lessons from the past	3
needed to determine if	3
moderate to severe tbi	3
patients with mild covid	3
in those with a	3
risk for vte in	3
as we anticipate that	3
patients with metastatic disease	3
was considered statistically significant	3
patients with atraumatic sah	3
previously healthy year old	3
and von willebrand factor	3
during induction therapy for	3
for the experimental group	3
of an accompanying person	3
a growing body of	3
daily for five days	3
understand the impact of	3
the clinical and laboratory	3
was a year old	3
local and systemic inflammation	3
degree of gene expression	3
or with markedly elevated	3